Schedule 13G ownership disclosure
BRIACELL THERAPEUTICS CORP
Common Shares, no par value · CUSIP: 107930307
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Iroquois Capital Management, LLC
Shares: 57,200.00 · Class: 2.95%
- Richard Abbe
Shares: 98,944.00 · Class: 4.99%
- Kimberly Page
Shares: 57,200.00 · Class: 2.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-25-003462
- Form type
- SCHEDULE 13G/A
- Filer
- Bionano Genomics, Inc.
- CIK
- CIK 1411690
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership